Billing
2026 Part B portable x-ray reimbursement rates - response to comments
This article contains the response to comments for the 2026 preliminary Part B portable x-ray transportation rates and a link to the final 2026 rates.
Process for supplying invoice amount on certain HCPCS codes - avoid rejected claims
Please review the revised blood product codes list.
Avoiding MSP claim rejects
Providers billing Medicare must determine if Medicare is the primary payer or not. This article has tips on checking MSP eligibility and avoiding MSP claim rejects.
Process for CPT category III T codes
Review the revised listing of CPT category III T codes that require documentation to avoid negative impacts to your claims.
Process for CPT category III T codes
Review the revised listing of CPT category III T codes that require documentation to avoid negative impacts to your claims.
New high-cost cell-based gene therapy drug Encelto approved for use in the ambulatory surgical center (ASC) setting
Medicare approved the groundbreaking new cell-based gene therapy drug, Encelto, for use in the ambulatory surgical center setting, effective for claims with dates of service on or after October 1,…
E/M: Reviewing amount and/or complexity of data
For the element of medical decision making addressing the amount and/or complexity of data to be reviewed and analyzed, the AMA Levels of Medical Decision Making table indicates: "Each unique test,…
E/M: Reviewing amount and/or complexity of data
For the element of medical decision making addressing the amount and/or complexity of data to be reviewed and analyzed, the AMA Levels of Medical Decision Making table indicates: "Each unique test,…
MSP billing
Read this article for more information on billing your claims when Medicare is the secondary payer.
Hepatitis C virus (HCV)
Read this article for more information on the hepatitis C virus and treatments covered by Medicare.